Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Closes $57M Financing; Will Use Funds to Commercialize Verigene, Biobarcode Systems

NEW YORK, May 16 (GenomeWeb News) - Nanosphere said today that it has closed $57 million in a Series D financing led by Bain Capital.

 

The company will use the funding to commercialize its Verigene System, a genomic testing platform that Nanosphere said eliminates the need for PCR.

 

Nanosphere will also use the proceeds to further development and commercialization of its Biobarcode technology for detecting proteins and nucleic acids.

 

Other investors in the round include Allen & Company and founding investor Lurie Investments.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.